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Background: Dysbindin and Disrupted-in-schizophrenia 1 (DISC1) are major schizophrenia susceptibility factors.
Results: DISC1 enhances stability of dysbindin, which is critical for neurite outgrowth.
Conclusion: Dysbindin and DISC1 form a physiologically functional complex that is essential for normal neurite
outgrowth.
Significance: Our findings indicate the existence of a protein complex composed of multiple schizophrenia susceptibility
factors functioning in a pathway for neurite outgrowth.
Dysbindin andDISC1 are schizophrenia susceptibility factors
playing roles in neuronal development. Here we show that the
physical interaction between dysbindin andDISC1 is critical for
the stability of dysbindin and for the process of neurite out-
growth. We found that DISC1 forms a complex with dysbindin
and increases its stability in associationwith a reduction inubiq-
uitylation. Furthermore, knockdown of DISC1 or expression of
a deletion mutant, DISC1 lacking amino acid residues 403–504
of DISC1 (DISC1403–504), effectively decreased levels of endog-
enous dysbindin. Finally, the neurite outgrowth defect induced
by knockdown of DISC1 was partially reversed by coexpression
of dysbindin. Taken together, these results indicate that dysbin-
din andDISC1 form a physiologically functional complex that is
essential for normal neurite outgrowth.
Neurite outgrowth is a critical process in neuronal develop-
ment. Abnormalities in this process have been linked to the
biological basis of various mental illnesses (1–3). Especially,
defects in neurite outgrowth have been proposed to underlie
the reduced neuropil hypothesis stating that schizophrenia is
involved in a decrease in axons and dendrites (4–8). In support
of this hypothesis, themultiple schizophrenia susceptibility fac-
tors, including Disrupted-in-schizophrenia 1 (DISC1) and dys-
trobrevin-binding protein 1 (dysbindin, DTNBP1) (9–11), are
involved in neurite outgrowth (12, 13).
Dysbindin was initially identified as an interactor of dystro-
brevin in muscle and brain (14). Subsequent genetic studies
have associated dysbindin with schizophrenia (10, 15–18).
Consistent with these findings, the sandy (sdy) mouse strain,
which lacks functional dysbindin, displays significant schizo-
phrenia-like behaviors, including deficits in social interaction
and working memory (19–22). Dysbindin mRNA and protein
are reduced significantly in schizophrenic patients (23, 24).
Notably, dysbindin is also involved in several neuronal develop-
mental processes, including neurite outgrowth. Knockdown of
dysbindin results in disorganization of the actin cytoskeleton
and shortening of neurites, and sandy mice show defective
neurite outgrowth and abnormal growth cone morphology
(12, 13, 25). Moreover, a recent report shows that dendritic
spine morphogenesis depends on the interaction of dysbin-
din with WAVE2 and Abi-1 (26), underscoring the essential
function of dysbindin.
DISC1 has emerged as a susceptibility factor in mental dis-
orders on the basis of the cosegregation of a balanced chromo-
somal translocation (t1;11) that disrupts the DISC1 gene in
multiple psychiatric conditions, including schizophrenia (10).
Subsequently, mice that are defective in DISC1 display neuro-
anatomical and behavioral abnormalities relevant to schizo-
phrenia (27, 28). Furthermore, DISC1 plays multiple roles dur-
ing neurodevelopment, including neuronal proliferation (29),
neurite outgrowth (3, 30–32), neuronal migration (29, 33, 34),
and synapse formation (35), all implicated in the pathophysiol-
ogy of schizophrenia.
A considerable number of studies have characterized inter-
acting partners of dysbindin and DISC1. Interestingly, several
reports show that the protein interaction networks associated
with dysbindin and DISC1 share common components,
implying a common physiological pathway for these two
major schizophrenia susceptibility factors (36, 37). Consis-
tent with this, dysbindin and DISC1 physically associate in
vitro, although the biological relevance of this has not been
investigated (38). In this study, we demonstrate the func-
tional collaboration of dysbindin and DISC1 in the neurite
outgrowth process which involves fine-tuning of dysbindin
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degradation by DISC1, and provide evidence of a convergent
pathway where dysbindin and DISC1, two schizophrenia-
associated proteins, cooperate.
EXPERIMENTAL PROCEDURES
Plasmids—For yeast two-hybrid assays, pPC97-DISC1 and
pPC86-NDEL1were prepared as described previously (39). The
human dysbindin coding sequence was amplified by PCR from
a human dysbindin cDNA clone (clone ID 4139934, Open Bio-
systems, GenBank accession number BC011912) and inserted
into the pPC86 vector (Invitrogen) using the SalI andNotI sites.
Full-length human andmouseDISC1 constructswere prepared
as described previously (39). For constructs of DISC1 frag-
ments, corresponding regions of human DISC1 (hDISC1) were
amplified by PCR and inserted into the pEGFP-C3 (Clontech)
and pFLAG-CMV2 (Sigma). For mouse dysbindin constructs,
the full-length dysbindin coding sequence was amplified using
reverse transcription products generated from CAD2 mouse
neuroblastoma cells, subcloned into pEGFP-N1 (Clontech),
pUB-GFP (Addgene), pFLAG-CMV2 (Sigma), and pCDNA3.1
Myc-His (Invitrogen). To construct the deletionmutant of dys-
bindin, a region of human dysbindin corresponding to the des-
ignated codonwas amplified by PCRusing EGFP-dysbindin as a
template and inserted into pEGFP-N1. Sequences were verified
by DNA sequencing. For shRNA constructs, mouse DISC1
shRNAwas prepared following a previous description (39). The
oligonucleotide sequences used for the constructs were GTGAT-
AAGTCAAGA GAAGCTTCAAGAGAGCTTCTCTTGACTT-
ACACTTTTTT and TCGAGAAAAAAGTGATAA GTCAAG-
AGAAGCTCTCTTGAAGCTTCTCTTGACTTAT CACA for
mouse dysbindin. These oligonucleotides were annealed and
ligated into thepLentiLox3.7 vectorusing theHpaI andXhoI sites.
To generate the shRNA-resistant GFP-mouse DISC1 and mouse
dysbindin constructs by inserting silent mutations in the shRNA
target sequence in pUB-GFP (Addgene), site-directed mutagene-
sis of DISC1 and dysbindin was performed using PCR-based
methods. The PCR primer sequences used were as follows:
5-AAG ACT TTA AGT GAC AAA TCA AGG GAG GCA
AAAGTGAAA-3 for dysbindin and 5-CGCACAATGAAGGC-
CAATACCGTCAAATGTATGGAAGTGTTG-3 for DISC1.
Cells and Transfections—HEK293T, HEK293, COS7, and
CAD cells were grown in DMEM supplemented with 10% fetal
bovine serum and antibiotics under 5%CO2 at 37 °C. Cells were
transfected using Lipofectamine 2000 (Invitrogen) or Viva-
Magic (Vivagen) according to the instructions of the manufac-
turer. For neuronal cultures, developing corticeswere dissected
from embryonic day 15 Institute for Cancer Research (CrljBgi:
CD-1) mouse embryos in Hanks’ balanced salt solution (Invit-
rogen). Dissected tissue was dissociated by treatment with
DNase I (0.1%) and Trypsin (0.25%) for 6 min at 37 °C. The
dissociated cells were diluted in plating medium, Neurobasal
medium (Invitrogen) containing 10 mM HEPES (pH 7.4) and
10% horse serum (Gibco), and then plated onto cover slips
coated with poly-D-lysine. Platingmedia was replaced with cul-
ture media (Neurobasal media supplemented with 2% B27
(Invitrogen), 2 mM glutamine, and antibiotics).
Antibodies and Immunoblot Analyses—Rabbit polyclonal
anti-dysbindin was used as described previously (26). Anti-
mDISC1 antibodieswere a gift fromDr. Kaibuchi (University of
Nagoya). A rabbit polyclonal anti-GFP protein (Molecular
Probes), anti-FLAG (ABR), and mouse monoclonal anti-FLAG
M2 (Sigma) were used. Anti- tubulin (catalog no. DM1A),
anti-GAPDH (catalog no. 6C5), anti-GFP (catalog no. B-2),
anti-DISC1 (catalog no. N-16), and anti-Myc (catalog no. 9E10)
antibodieswere purchased fromSantaCruz Biotechnology. For
immunoblotting, cells were lysed in Nonidet P-40 lysis buffer
(50 mM Tris (pH 8.0), 150 mM NaCl, 1% Nonidet P-40, 5 mM
EDTA, 5 mM glycerol-2-phosphate, 2 mM sodium pyrophos-
phate, 5 mM NaF, 2 mM Na3VO4, 1 mM DTT, and EDTA-free
protease inhibitor mixture (Roche)) and precleared by centri-
fugation for 10min at 12,000 g. Supernatants were denatured
in SDS sample buffer by boiling for 5 min and subjected to
SDS-PAGE followed by immunoblotting.
Immunoprecipitation and in Vitro Binding Assay—Whole
brain tissues from an Institute for Cancer Researchmouse were
homogenized in Nonidet P-40 lysis buffer and precleared by
centrifugation for 15 min at 12,000  g. Supernatants were
incubated with antibody (0.5–1 g) on a rocking platform for
2 h or overnight at 4 °C, and then 100 l of 10% protein A-aga-
rose (GE Healthcare) resuspended in the same lysis buffer was
added and incubated with gentle shaking for an additional 90
min at 4 °C. The precipitate was washed three times with lysis
buffer and resuspended in 2 SDS sample loading buffer. For
the in vitro binding assay, transfected HEK293T cell lysates
were incubated with 1 g of anti-FLAG M2 (Sigma) antibody
for 2 h at 4 °C, and then protein A-agarose beads (GE Health-
care)were added and incubated for an additional 90min at 4 °C.
Precipitates werewashed three timeswith lysis buffer and incu-
bated with 5 g of GST-dysbindin for 2 h at 4 °C. Beads were
collected by centrifugation at 2000  g and rinsed four times
with lysis buffer. Precipitates were subjected to anti-GST and
anti-FLAG immunoblotting.
Immunocytochemistry—Cells were fixed for 10 min in 4%
paraformaldehyde in PBS and incubated for 30 min in blocking
solution (2% goat serum and 1% Triton X-100 in PBS). Cells
were incubated with anti-Myc (1:200, Santa Cruz Biotechnol-
ogy) and rabbit anti-GFP antibodies (1:2000,Molecular Probes)
for 1.5 h at room temperature, followed by incubation with
Alexa Fluor 488-conjugated goat anti-rabbit IgG and Alexa
Fluor 568-conjugated goat anti-mouse IgG secondary antibod-
ies (Molecular Probes) for 1 h at room temperature. Hoechst
dye was used for nuclear staining, and cells on coverslips were
rinsed three times with PBS and mounted in antifade medium
(Molecular Probes). Pictures were taken with a confocal micro-
scope (Olympus, FluoView-1000).
Ubiquitylation Analysis—HEK293 cells were transfected
with HA-ubiquitin (a gift from Dr. Chin Ha Chung, Seoul
National University, Seoul, Korea) along with Myc-dysbindin
and EGFP-DISC1 constructs. 48 h after transfection, cells were
treated with 25MMG132 (Enzo) for 8 h prior to lysis. The cell
lysates were prepared in Nonidet P-40 lysis buffer with 10
mM N-ethylmaleimide and incubated with anti-Myc anti-
2 The abbreviations used are: CAD, Cath.a-differentiated; EGFP, enhanced
GFP; ANOVA, analysis of variance; UPS, ubiquitin-proteasome system; FL,
full-length.
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bodies for 4 h. Protein A-agarose beads were washed three
times with lysis buffer, and immunoprecipitated proteins
were eluted in 2 SDS/PAGE sampling buffer and analyzed
by immunoblotting with anti-Myc, anti-GFP, and anti-HA
antibodies.
Neurite Outgrowth Assay—CAD cells were cultured in
DMEM containing 10% FBS and antibiotics for 1 day and then
transfected with the indicated constructs using VivaMagic
(Vivagen). After 48 h of transfection, cells were detached using
trypsin, diluted in DMEM with antibiotics, seeded again onto
12-well plates, and cultured for 72 h. Neurites on 150–250
fluorescent cells from three independent experiments were
selected randomly, and neurites longer than the diameter of the
soma were measured by ImageJ software (National Institute of
Health). The length of the longest neurite and total neurite
length were used for analyses. For cultured primary neurons,
control red fluorescent protein (RFP) vector or RFP-expressing
shRNAs were transfected into cells to visualize the neuronal
morphology using Lipofectamine 2000 at days in vitro 0 and
cultured for 3 days. Neurons were fixed, and neurite length was
measured in randomly selected microscopic fields using a20
objective. Neurites on 190–249 transfected neurons from three
independent experiments were measured by ImageJ software
and analyzed blindly.
FIGURE 1. Dysbindin interacts with DISC1. A, yeast two-hybrid assay using a -galactosidase reporter. Cotransformation with pPC97-DISC1 and pPC86-
NDEL1 was used as a positive control. B, interaction of dysbindin (Dysb) and DISC1 in an in vitro binding assay. IP, immunoprecipitation. C, reciprocal coimmu-
noprecipitationof dysbindinwithDISC1. Lysates fromHEK293T cells transfectedwithdysbindin andDISC1were immunoprecipitatedwith anti-GFP (toppanel)
or anti-Flag (bottom panel) antibodies. Immunoprecipitates were analyzed by immunoblotting with anti-FLAG and anti-GFP antibodies.D, coimmunoprecipi-
tation of endogenous dysbindin and DISC1 from mouse brain lysates. Anti-dysbindin immunoprecipitates were analyzed by immunoblotting with anti-
dysbindin and anti-DISC1 antibodies. E, colocalization of dysbindin and DISC1 in HEK293 cells shown by immunocytochemistry. Myc-dysbindin and EGFP-
DISC1 were stained with anti-Myc (red) and anti-GFP (green) antibodies. Nuclei were stained with Hoechst dye (blue). Scale bars  10 m. F, schematic of
dysbindin fusion proteins used for coimmunoprecipitation analyses. aa, amino acids; FL, full-length. G, coimmunoprecipitation assays with DISC1 fragments
and Myc-dysbindin. A schematic of DISC1 fusion proteins is also shown.
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Statistical Analysis—Data were analyzed using GraphPad
Prism 5 software and are presented as mean S.E. Statistical
significance was determined by ANOVA or Student’s t test.
RESULTS
Dysbindin Interacts with DISC1—To examine whether dysbin-
din interacts with DISC1, we employed a yeast-two-hybrid assay.
We found that cotransformants containing dysbindin and DISC1
showed a positive signal, indicating interaction-dependent -ga-
lactosidase activity (Fig. 1A). DISC1 and NDEL1 (nudE nuclear
distribution gene E homolog (A. nidulans)-like 1) were used as
positive controls in this assay. In addition, GST-dysbindin also
interacteddirectlywithFLAG-DISC1purifiedby immunoprecipi-
tation (Fig. 1B). Moreover, reciprocal coimmunoprecipitation of
dysbindin and DISC1 was detected consistently in transfected
HEK293T cell lysates (Fig. 1C), indicating potential protein com-
FIGURE 2. DISC1 up-regulates dysbindin. A, up-regulation of dysbindin (Dysb) protein by DISC1 coexpression. 30 h after transfection with the indicated
plasmids. Cells were subjected to immunoblotting analyses. Error bars showmean S.E. ***, p0.001 by Student’s t test (n 3). B, no changes in the level of
dysbindinmRNA by DISC1 coexpression. DysbindinmRNA levels weremeasured by RT-PCR and normalized to GAPDHmRNA.NS, not significant by Student’s
t test (n 3). C, dose-dependent increases in dysbindin protein by DISC1. Dysbindin protein levels were normalized to GAPDH. Error bars showmean S.E. *,
p 0.05; **, p 0.01 by Student’s t test (n 3). D, down-regulation of dysbindin protein by knockdown of DISC1 in differentiated CAD cells . Error bars show
mean S.E. **, p 0.01; ***, p 0.001 by Student’s t test (n 6). E, reduction ofMG132 efficacy on dysbindin by coexpression of DISC1. 30 h after transfection,
MG132 (10 M) was treated for 8 h in a. Protein levels relative to control cells are shown in b, and the relative increase in dysbindin upon MG132 treatment is
shown in c. Error bars showmean S.E. *, p 0.05; ***, p 0.001; Student’s t test (n 3). DMSO, dimethyl sulfoxide. F, decreased ubiquitylation of dysbindin
followingDISC1 coexpression. HEK293 cells were cotransfectedwith the indicated plasmids, treatedwithMG132 for 8 h, followedby immunoprecipitation (IP)
and immunoblotting as indicated. Ub, ubiquitin.
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plex formation in the cellular context. Consistently, DISC1 and
dysbindin were coimmunoprecipitated from mouse brain lysates
(Fig. 1D). We also examined the subcellular localization of these
two proteins using immunocytochemistry in HEK293 cells. Con-
focal microscopy images showed significant colocalization
between Myc-dysbindin and EGFP-DISC1 in the cytoplasm (Fig.
FIGURE 3.DISC1enhancesdysbindin stability.A, up-regulationof dysbindin ismediatedbyDISC1 amino acid residues 345–854. FL, full-length;aa, amino acids.B,
increased expressionof dysbindin (Dysb) upon coexpressionwithDISC1403–504. 30 h after transfectionwith the indicatedplasmids, cellswere harvested for immuno-
blotting analyses. C, effect of DISC1403–504 coexpression on dysbindin stability. HEK293T cells were treatedwith 100g/ml cycloheximide (CHX) 30 h after cotrans-
fection of EGFP-dysbindin constructs with either full-length DISC1 or DISC1403–504. Dysbindin levels were quantified by immunoblotting. Representative data are
shown in a, and the relative dysbindin protein level at time 0 is shown in b. Error bars showmean S.E. ***, p 0.001 by one-wayANOVAwith Bonferroni’smultiple
comparison test (n 4); NS, not significant. c, the dynamics indicating the remaining protein levels of dysbindin were measured as a ratio of the value at time 0 in
thesamegroup.ErrorbarsshowmeanS.E. *,p0.05; ***,p0.001versusEGFP-dysbindinwithemptyvector (MOCK)byone-wayANOVAwithBonferroni’smultiple
comparison test (n 4).D, down-regulation of dysbindin protein by overexpression of DISC1403–504. COS7 cells were transfected with either EGFP-DISC1 or EGFP-
DISC1403–504 and subjected to immunoblotting. Error bars showmean S.E. *, p 0.05 by one-way ANOVAwith Bonferroni’smultiple comparison test (n 3).
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1E). Taken together, these results suggest that dysbindin and
DISC1 form a physiologically functional complex.
We next attempted to identify the protein subregions medi-
ating the interaction between dysbindin and DISC1. A series of
deletion mutants of dysbindin were generated on the basis of
domain predictions, and their interactions with DISC1 were
assayed by coimmunoprecipitation in HEK293T cells. As
shown in Fig. 1F, the unstructured N-terminal and coiled-coil
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domains of dysbindin (residues 1–87 (dysbindin1–87) and
88–180 (dysbindin88–180), respectively) were coimmunopre-
cipitated with full-length DISC1, whereas the dysbindin C
terminus (residues 181–351, dysbindin181–351) was not. Con-
versely, we also analyzed the interaction of full-length
dysbindin with EGFP-tagged fragments of DISC1 (residues
1–350, 345–591, and 586–854). DISC11–350 and DISC1345–591
were both coimmunoprecipitated with full-length dysbindin,
whereas DISC1586–854 was not (Fig. 1G). Therefore, the inter-
action between dysbindin and DISC1 involves a rather broad
interface encompassing residues 1–180 of dysbindin and resi-
dues 1–591 of DISC1.
DISC1 Protects Dysbindin from the Ubiquitin-Proteasome
System—The reduction of dysbindin protein in schizophrenic
patients has been shown previously (23, 24), implying that the
abundance of dysbindin can be associated with the disease. It
has been reported recently that TRIM32, a ubiquitin E3 ligase,
ubiquitylates dysbindin and facilitates its degradation (40).
Moreover, some reports hint at the possibility that DISC1
affects the ubiquitylation and stability of multiple DISC1-inter-
acting proteins (39, 41). In this line, we examined whether
DISC1 regulates stability of dysbindin protein by monitoring
dysbindin level transiently transfected in the presence or
absence of DISC1 coexpression. The results showed a remark-
able increase in dysbindin following transfection with DISC1
(Fig. 2A) without alteration of the dysbindin mRNA level (Fig.
2B). In addition, the degree of increase in dysbindin showed a
strong correlationwith theDISC1 expression level (Fig. 2C). To
ascertain whether DISC1 is essential for maintaining the
endogenous dysbindin protein level, we introduced shRNA
constructs targeting DISC1 into Cath.a-differentiated (CAD)
mouse neuroblastoma cells. The level of dysbindin protein was
reduced significantly following knockdown of DISC1 (Fig. 2D).
Dysbindin is degraded by the ubiquitin-proteasome system
(UPS) (40). Therefore, we used the proteasome inhibitor
MG132 to test whetherDISC1 affects dysbindin stability via the
UPS. As shown in Fig. 2E, dysbindin was up-regulated dramat-
ically followingMG132 treatment (Fig. 2E,a and b). Indeed, this
up-regulationwas decreased under coexpression ofDISC1 (Fig.
2E, c). Moreover, a significant decrease in dysbindin ubiquity-
lation was consistently detected upon coexpression of DISC1
(Fig. 2F). In sum, these results indicate thatDISC1 enhances the
stability of dysbindin, at least in part, by protecting dysbindin
from ubiquitylation-dependent proteasomal degradation.
Amino Acid Residues 403–504 of DISC1 Are Involved in the
Regulation of Dysbindin Stability—We next investigated which
regions of DISC1 were important for regulating dysbindin.
Interestingly, the level of dysbindin protein was up-regulated
upon coexpression of DISC1345–591 and DISC1586–854, compa-
rable with the effect of full-length DISC1 coexpression (Fig.
3A), indicating that the effect of DISC1 on dysbindin stability
was dependent on amino acid residues 345–854. Although the
C-terminal part ofDISC1 is not responsible for interactionwith
dysbindin, amino acid residues 345–591 are involved in the
physical interaction and have the capacity to protect dysbindin
from degradation. Therefore, we attempted to further narrow
down the region of DISC1 responsible for regulating dysbindin
stability. We separated the region into five fragments, amino
acid residues 345–506, 403–504, 506–591, 586–700, and 696–
854 (DISC1345–506, DISC1403–504, DISC1506–591, DISC1586–700,
and DISC1696–854, respectively) without disrupting the pre-
dicted coiled-coil structures and tested the impact ondysbindin
stability upon coexpression. Although both fragments of
C-terminal DISC1 (DISC1586–700 and DISC1696–854) did not
result in a noticeable effect on dysbindin, DISC1345–506 and
DISC1403–504 caused an up-regulation of dysbindin levels (Fig.
3B). This result may reflect that DISC1403–504 can mediate the
enhancement of dysbindin stability by direct interaction, which
is consistent with a recent report showing that incubation of puri-
fied dysbindin with a recombinant DISC1 fragment containing
amino acid residues 316–854 with a deletion of amino acid resi-
dues403–504didnot result inanadditionalhighermolecularpeak
in size exclusion chromatography (supplemental data in Ref. 38).
On the basis of this information, we introduced DISC1 lacking
thisregion,DISC1403–504, intotheanalysis.Weobservedaconsis-
tent decrease in dysbindin protein upon coexpression of
DISC1403–504 compared with full-length DISC1, suggesting that
amino acid residues 403–504 of DISC1 are critical for preventing
dysbindin fromdegradation (Fig. 3C, a and b). To further confirm
this, we compared the stability of dysbindin upon coexpression of
either full-lengthDISC1orDISC1403–504 in cycloheximide chase
experiments. In these experiments, the dysbindin level declined
more rapidly upon coexpression ofDISC1403–504 comparedwith
full-length DISC1 (Fig. 3C, c). Furthermore, expression of
DISC1403–504 caused a reduction in endogenous dysbindin (Fig.
3D), further supporting the notion that amino acid residues 403–
504ofDISC1 are important for protecting dysbindin fromprotea-
some-mediated degradation.
FIGURE 4. DISC1 affects the dysbindin-mediated neurite outgrowth process. A, characterization of shRNA constructs. a, knockdown of endogenous
dysbindin (Dysb) by dysbindin shRNA in differentiated CAD cells (n  3). Error bars show mean  S.E. ***, p  0.001 by Student’s t test. b, expression of
shRNA-resistant DISC1 and dysbindin. B, neurite outgrowth defects in DISC1 and dysbindin knockdown CAD cells. Shown are representative images of
differentiated CAD cells transfected with shRNA constructs alone or in combination with rescue constructs of DISC1 and dysbindin (a). The longest neurite
length (b) and total neurite length (c) weremeasuredusing ImageJ software andnormalized to the control group (n 243 for control shRNA,n 237 forDISC1
shRNA, n 245 for dysbindin shRNA, n 215 for DISC1 shRNADISC1 rescue, and n 217 for dysbindin shRNAdysbindin rescue). Error bars showmean
S.E. ***, p 0.001 by one-way ANOVA with Bonferroni’s multiple comparison test. C, inhibition of neurite outgrowth by coexpression of DISC1403–504. The
longest neurite length (a) and total neurite length (b) were analyzed in CAD cells differentiated 3 days (n 193 for MOCK, n 237 for DISC1 FL, and n 223
for DISC1403–504). Error bars showmean S.E. ***, p 0.001 by one-way ANOVAwith Bonferroni’smultiple comparison test.D, partial rescue of the dysbindin
knockdownphenotype by coexpression of DISC1. The longest neurite length (a) and total neurite length (b) are shown (n 211 for control shRNA, n 210 for
dysbindin shRNA, n 193 for dysbindin shRNADISC1 FL, and n 106 for dysbindin shRNADISC1403–504). Error bars showmean S.E. *, p 0.05; **, p
0.01; ***,p0.001;NS,not significant byone-wayANOVAwithBonferroni’smultiple comparison test. E, reversal of theneurite outgrowthdefects bydysbindin
coexpression in DISC1 knockdown cells. The longest neurite length (a) and total neurite length (b) are shown (n 192 for control shRNA, n 219 for DISC1
shRNA, and n 219 for DISC1 shRNA dysbindin). Error bars showmean S.E. ***, p 0.001 by one-way ANOVAwith Bonferroni’smultiple comparison test.
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DISC1 Regulates Dysbindin-mediated Neurite Outgrowth—
Dysbindin is involved in neurite outgrowth in differentiated
neuroblastoma cells and primary neurons (12, 13, 25). Compa-
rable neurite outgrowth defects are caused by deficiencies in
DISC1 function (3, 30–32). Therefore, we attempted to test
whether DISC1 and dysbindin are involved in neurite out-
growth through a common pathway. For this, shRNA against
the mouse form of dysbindin (Fig. 4A, a), shRNA-resistant
mouse dysbindin, and DISC1 constructs (Fig. 4A, b) were gen-
erated and utilized for neurite outgrowth assays in CAD cells.
Consistent with previous observations, the longest neurite and
total neurite length were both reduced significantly by shRNA-
mediated knockdown of either dysbindin or DISC1. A remark-
able restoration of neurite outgrowth by coexpression with
shRNA-resistant DISC1 and dysbindin in knockdown cells was
also observed, verifying the target specificity of knockdown
constructs (Fig. 4B). Notably, although the full-length DISC1
did not influence neurite length, small but significant reduc-
tions of the longest neurite and total neurite length were
observed upon overexpression of DISC1403–504 (Fig. 4C).
Although the stability of dysbindin in HEK293 cells was
increased upon coexpression of full-length DISC1, the neurite
outgrowth in CAD cells was not affected, implying that the
endogenous level of DISC1 in CAD cells appears sufficient to
ensure maximal neurite outgrowth.Moreover, we testedwhether
DISC1 can affect neurite outgrowth in CAD cells by stabilization
of dysbindin protein held at low levels in dysbindin knockdown
cells. Indeed, the defects in neurite outgrowth in dysbindin knock-
down cells were partially rescued by coexpression of full-length
DISC1 but not by DISC1403–504, supporting the hypothesis that
DISC1 affects the availability of dysbindin protein in the cell (Fig.
4D). To characterize the cooperation of DISC1 and dysbindin, we
examined whether the DISC1 knockdown phenotype can be
restored by dysbindin coexpression. Indeed, the neurite out-
growth defects caused by DISC1 knockdown were significantly
restored by dysbindin coexpression (Fig. 4E). These results collec-
tively indicate that DISC1 and dysbindin collaborate in the regu-
lation of neurite outgrowth.
We also examined neurite outgrowth in primary cultured
mouse cortical neurons. The longest neurite and total neurite
length were both reduced significantly upon knockdown of either
dysbindinorDISC1 (Fig. 5A).Moreover, significantly shorterneu-
rite lengths in the longest neurite and total neurite length were
observed upon overexpression of DISC1403–504 compared with
theoverexpressionof full-lengthDISC1 (Fig. 5B).These results are
largely consistentwith theCADcell results and support thenotion
thatDISC1 anddysbindin not only play roles but also cooperate in
the regulation of neurite outgrowth.
DISCUSSION
In this study,wedescribe thephysical and functional interaction
between DISC1 and dysbindin, two major schizophrenia suscep-
tibility factors.We found thatDISC1physically interactswithdys-
FIGURE 5. Compromised neurite outgrowth by deficiencies in DISC1 and
dysbindin in primary cortical neurons. A, neurite outgrowth defects in
DISC1- and dysbindin (Dysb) shRNA-transfected cortical neurons. Shown are
representative images of cortical neurons transfected with indicated shRNA
constructs (a). The longest neurite length (b) and total neurite length (c) were
analyzed. Neurites on 	249 transfected neurons from three independent
experiments were measured and normalized to control cells (n  214 for
control shRNA, n  249 for DISC1 shRNA, and n  192 for dysbindin
shRNA). Error bars show mean  S.E. ***, p  0.001 by Student’s t test. B,
inhibition of neurite outgrowth by DISC1403–504 coexpression. Shown are rep-
resentative images of cortical neurons transfected with full-length DISC1 or
DISC1403–504 (a). The longest neurite length (b) and total neurite length (c)were
analyzed (n 193 for DISC1 FL and n 223 for DISC1403–504). Neurons were
transfected with constructs for GFP-DISC1 FL or GFP-DISC1403–504 in combina-
tionwith the red fluorescentprotein (RFP) construct (ratio 3:1) at days in vitro0 to
visualize neuronal morphology. Error bars show mean S.E. ***, p 0.001 by
Student’s t test.
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bindin and stabilizes the protein by decreasing its ubiquitylation.
Although the interaction was mediated by a broad region of
DISC1, its capacity to up-regulate dysbindin appeared to be
restricted to a relatively specific region (amino acid residues 403–
504). Finally, we demonstrated that DISC1 and dysbindin cooper-
ate in the neurite outgrowth process. The potential functional
interaction between DISC1 and dysbindin has been suggested on
thebasis of their closeproximity in theprotein-protein interaction
networkof schizophrenia susceptibility factors (36, 37).Moreover,
a recent report showed a colocalization ofDISC1 anddysbindin in
cellular aggresomes and the association of purified recombinant
dysbindin and DISC1 (38). However, it was unclear whether
DISC1 and dysbindin interact under more physiological condi-
tions and what its functional relevance might be. In this line, our
results provide additional mechanistic insights, supporting the
idea thatmultiple schizophrenia susceptibility factors formacom-
mon biological pathway associated with the etiology of schizo-
phrenia and relatedmental illnesses.
We provided evidence indicating that DISC1 affects dysbindin
functions by enhancing its stability. Studies have revealed
extended roles for the UPS in neuronal growth and development,
synaptic function and plasticity, and pathway-specificmodulators
(42–44). However, only few UPS-associated players have been
studied in neurons so far, andmany components and functions of
the UPS in the neuronal system have yet to be identified. Interest-
ingly, in addition to the DISC1 region responsible for the interac-
tion with dysbindin, the C-terminal region of DISC1 (amino acid
residues 586–854) appears to be involved in the dysbindin level in
an interaction-independentmanner.This is consistentwithprevi-
ous reports showing that the C-terminal region of DISC1 partici-
pates in controlling the stability of the counterpart-interacting
proteins by affecting their ubiquitylation levels (39, 41). These
results raise the possibility that there might be a common ubiqui-
tin-associated mechanism involving the C-terminal region of
DISC1. The ubiquitylation state of a protein is determined by the
antagonistic activities of the ubiquitin-conjugating enzyme (E2)-
ubiquitin ligase (E3) complex and deubiquitylating enzymes (45,
46). Therefore, it is intriguing to speculate thatDISC1might affect
the function of either the ubiquitin-conjugating enzyme complex
or deubiquitylating enzymes to alter the stability of its binding
partners.
Although dysbindin was initially identified as a component
of the dystrophin-dystroglycan complex, subsequent studies
showed that dysbindin in the brain exists as a stable component
of biogenesis of lysosome-related organelles complex 1 (BLOC-
1), a multiprotein complex containing at least eight compo-
nents (dysbindin (dystrobrevin-binding protein 1, DTNBP1),
muted (MUTED), pallidin (PLDN), cappuccino (CNO), snapin
(SNARE-associated protein, SNAPAP), and biogenesis of lyso-
some-related organelles complex 1, subunit 1–3 (BLOC1S1–
3)) with functions in organelle biogenesis and intracellular
membrane trafficking (12, 47–49). It is notable that other
BLOC-1 subunits, BLOC1S2, BLOCIS3, and MUTED, have
been reported to be potential susceptibility factors of schizo-
phrenia (2, 50, 51) and that a deficiency in BLOC-1 induces
neurite outgrowth defects in rodent hippocampal neurons (12).
Interestingly, destabilization of dysbindin protein has been
observed consistently in muted (mu) (51, 52) and pallid (pa)
mice (12, 52), implying the potential importance of decreased
dysbindin stability as a common cellular correlative associated
with schizophrenia. Taken together, the findings in this study
suggest that DISC1 may regulate the integrity of BLOC-1 and
that dysbindin mediates this interplay among multiple schizo-
phrenia susceptibility factors.
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